Skip to main content
Therapeutic Advances in Hematology logoLink to Therapeutic Advances in Hematology
. 2021 Jun 23;12:20406207211027370. doi: 10.1177/20406207211027370

CORRIGENDUM to “Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?”

PMCID: PMC8239966  PMID: 34249301

Byun JM, Shin D-Y, Koh Y, et al. Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission? Therapeutic Advances in Hematology. January 2021. DOI: 10.1177/20406207211001135

In the above article the correct authorship sequence is as follows:

Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon, Ji Yun Lee, Soo-Mee Bang and Jeong-Ok Lee

Ji Yun Lee is affiliated with Hematology Department, Seoul National University Bundang Hospital, Seongnam, Korea.

The online files have also been corrected.


Articles from Therapeutic Advances in Hematology are provided here courtesy of SAGE Publications

RESOURCES